Clinical trial

Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing

NCT03511235

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-03-12

PhaseN/A

Study timeline

Study start (actual)2018-03-12Date precision: day

Registry last updated2020-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Sponsors & collaborators

Myriad Genetic Laboratories, Inc.lead sponsor

Mapped research locations

New YorkNew York, United States1 San FranciscoCalifornia, United States1 Ann ArborMichigan, United States1 Little RockArkansas, United States1 OrangeCalifornia, United States1 Colorado SpringsColorado, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03511235 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.